01—Abstract
Summary
Summary of the 10-K filed February 21, 2020. Cited figures are marked; the original filing is the authoritative source.
Aflac Incorporated's 2019 10-K filing reveals a company with robust financial performance, driven primarily by its Japanese operations which accounted for 69%a of total revenues.
Total revenues reached $22.3 billionb, with net earnings of $3.3 billion ($4.43 per diluted share). The company demonstrated strong capital positions, with shareholders' equity growing to $29.0 billion, bolstered by a significant net unrealized gain on investment securities. Aflac returned $2.4 billion to shareholders through share repurchases and dividends in 2019, indicating a commitment to shareholder value.
A key area of focus for investors is the impact of the Japan Post Group investigation and related sales suspensions, which led to a material decrease in Aflac Japan's sales through this channel, a trend expected to continue in the near term. Despite this challenge, Aflac Japan's core cancer and medical insurance products remain strong.
In the U.S., Aflac acquired Argus Dental & Vision, Inc., aiming to expand its dental and vision offerings. The company continues to navigate a complex regulatory environment and manages significant market risks, including interest rate sensitivity and foreign currency fluctuations, particularly the yen/dollar exchange rate.
02—Key points
Key Highlights
- Aflac Japan contributed significantly to total revenues (69%) and total assets (83%) in 2019, highlighting its strategic importance.
- Total revenues increased by 2.5% to $22.3 billion, and net earnings rose to $3.3 billion, or $4.43 per diluted share.
- Shareholders' equity increased to $29.0 billion, with a substantial net unrealized gain on investment securities of $8.5 billion.
- The company returned $2.4 billion to shareholders through share repurchases ($1.6 billion) and dividends ($0.8 billion) in 2019.
- Sales in the Japan Post Group channel for Aflac Japan's cancer insurance products saw a material decline starting in August 2019 due to improper sales practices investigations, with expectations of continued weakness in the near term.
- Aflac U.S. acquired Argus Holdings, LLC and its subsidiary for $75 million, plus up to $21 million in contingent consideration, to expand its dental and vision product offerings.
- The company maintains a strong capital position, with Aflac Japan's Solvency Margin Ratio (SMR) at 1,043% and Aflac's company action level RBC ratio at 539% as of December 31, 2019.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2019filed February 21, 2020Financial Statements
FY2019 against FY2018
| Line item | FY2019FY2018 | Change |
|---|---|---|
| Revenue | $22.31B$21.76B | +2.5% |
| SG&A Expenses | $3.09B$2.99B | +3.4% |
| Operating Expenses | $5.92B— | — |
| Operating Income | $4.46B$4.35B | +2.5% |
| Interest Expense | $228.00M$222.00M | +2.7% |
| Net Income | $3.30B$2.92B | +13.2% |
| EPS (Basic) | $4.45$3.79 | +17.4% |
| EPS (Diluted) | $4.43$3.77 | +17.5% |
| Shares Outstanding (Basic) | 742.41M769.59M | −3.5% |
| Shares Outstanding (Diluted) | 746.43M774.65M | −3.6% |
05—Questions
Frequently Asked Questions
What is the primary driver of Aflac's revenue and assets?
Aflac Japan is the primary driver of Aflac's revenue and assets. In 2019, Aflac Japan accounted for 69% of total revenues and held 83% of total assets, underscoring its significant contribution to the company's financial performance.
What are the main risks facing Aflac, as highlighted in the filing?
Key risks include the concentration of business in Japan, exposure to interest rate and foreign currency fluctuations (yen/dollar exchange rate), the potential for defaults and credit downgrades in its investment portfolio, and the impact of the ongoing Japan Post Group investigation on sales. Additionally, the company faces risks related to its IT systems, cybersecurity, and the ability to attract and retain sales associates.
How did Aflac manage its capital and shareholder returns in 2019?
In 2019, Aflac returned $2.4 billion to shareholders through share repurchases totaling $1.6 billion and dividend payments of $0.8 billion. The company maintained strong capital positions, with Aflac Japan's SMR at 1,043% and Aflac's RBC ratio at 539% as of December 31, 2019.
What is the expected impact of the Japan Post Group investigation on Aflac Japan?
The investigation into improper sales practices by the Japan Post Group has led to a material decrease in Aflac Japan's sales through this channel, starting in August 2019. The company anticipates this decline will continue in the near term and is uncertain about the long-term effects on its results of operations or financial condition.
06—Continue